drugset / Trial / NCT02483793

Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

NCT02483793

RandomizedParallel-groupTreatment

Summary

The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.

Timeline

Start
2015-07
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxybutynin Small molecule 0.5 mg/kg
Comparator Oxybutynin Small molecule 5 mg
Comparator Tamsulosin Other / unclassified 0.4 mg